As a surgical option, transcervical resection of uterine myomas is in the early stages of development. Although promising and a logical extension of the increasing reliance on hysteroscopy in gynecology, the comparison with the surgical standards of care for myomas (hysterectomy and hysterotomy) remains incomplete. The safety of the procedure, in the hands of a skillful resectionist, should be equivalent to that of a transurethral prostatectomy or bladder tumor resection. Postoperative management remains anecdotal, however, as the value of perioperative antibiotics, uterine stenting, or the administration of hormones to promote uterine healing has not been established.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!